| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(86)90363-6 |
| P698 | PubMed publication ID | 3019564 |
| P50 | author | Flossie Wong-Staal | Q3074353 |
| P2093 | author name string | Okamoto T | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29-35 | |
| P577 | publication date | 1986-10-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system | |
| P478 | volume | 47 |
| Q36070772 | A highly conserved, 5' untranslated, inverted repeat sequence is ineffective in translational control of the alpha 1(I) collagen gene |
| Q39872176 | A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. |
| Q40820999 | A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-kappaB signaling pathway |
| Q40113669 | A novel cis-acting element that controls transcription of human immunodeficiency virus type 1 DNA, depending on cell type |
| Q33787595 | Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system |
| Q39559552 | Advances in human retroviruses |
| Q34289422 | An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription |
| Q29618434 | An inducible transcription factor activates expression of human immunodeficiency virus in T cells |
| Q36831828 | Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats |
| Q45856643 | Analysis of the human immunodeficiency virus long terminal repeat by in vitro transcription competition and linker scanning mutagenesis |
| Q28370905 | Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells |
| Q45832890 | Augmentation and stable expression of a novel transcription factor SII in CD4-positive cells on infection with human immunodeficiency virus type-1 (HIV-1). |
| Q44016338 | Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization |
| Q45860235 | Binding of Tat Protein to TAR Region of Human Immunodeficiency Virus Type 1 Blocks TAR-Mediated Activation of (2′-5′)Oligoadenylate Synthetase |
| Q34164861 | Cap-binding proteins of eukaryotic messenger RNA: functions in initiation and control of translation |
| Q40109412 | Chemical synthesis of biologically active tat trans-activating protein of human immunodeficiency virus type 1. |
| Q46796894 | Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses |
| Q41565987 | Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1). |
| Q46448334 | Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia |
| Q40041542 | Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants |
| Q24673792 | Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation |
| Q45856315 | Formation of a small ribonucleoprotein particle between Tat protein and trans-acting response element in human immunodeficiency virus-infected cells |
| Q36873530 | Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. |
| Q52577483 | HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies. |
| Q35937536 | HIV-1 Tat protein promotes formation of more-processive elongation complexes |
| Q44349676 | HIV-1 tat trans-activation requires the loop sequence within tar. |
| Q38345116 | Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation |
| Q38319909 | Human neuroblastoma cells produce the NF-kappa B-like HIV-1 transcription activator during differentiation |
| Q39466471 | Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS. |
| Q40066797 | Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras |
| Q35792284 | Identification of transcriptional suppressor proteins that bind to the negative regulatory element of the human immunodeficiency virus type 1 |
| Q43189113 | Impaired plant growth and development caused by human immunodeficiency virus type 1 Tat. |
| Q24655901 | In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor |
| Q36882588 | Increased expression of CD4 molecules on Jurkat cells mediated by human immunodeficiency virus tat protein. |
| Q34352092 | Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor |
| Q33206918 | Interaction of prion protein mRNA with CBP35 and other cellular proteins: possible implications for prion replication and age-dependent changes |
| Q38348287 | Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus |
| Q37603547 | Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter |
| Q36825785 | Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat |
| Q35226113 | Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis |
| Q36831514 | Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity |
| Q36062164 | Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation |
| Q40129795 | Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat |
| Q40448541 | Overlapping redundant septuplets identical with regulatory elements of HIV-1 and SV40. |
| Q82507500 | Preferential expression and immunogenicity of HIV-1 Tat fusion protein expressed in tomato plant |
| Q36877486 | Promoters of bovine papillomavirus type 1: in vitro activity and utilization |
| Q35228905 | Protein Phosphorylation in Translational Control |
| Q40669160 | Quantification of the HIV transcriptional activator complex in live cells by image-based protein-protein interaction analysis |
| Q39289382 | Regulation of HIV and HTLV gene expression |
| Q40467663 | Regulation of HIV-1 Gene Expression by the Transactivator Protein Tat |
| Q41506409 | Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation |
| Q43468674 | Repressive effect of the nef cDNA of human immunodeficiency virus type 1 on the promoter activity of the viral long terminal repeat |
| Q24645992 | Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat |
| Q42613105 | Sequence analysis of the simian foamy virus type 1 genome |
| Q67913230 | Sequence-specific toxicity of transfected retroviral DNA |
| Q24645645 | Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation |
| Q36782740 | Simian immunodeficiency virus displays complex patterns of RNA splicing. |
| Q36788702 | Simian virus 40 major late promoter: a novel tripartite structure that includes intragenic sequences |
| Q24645001 | Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription |
| Q34284937 | Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region |
| Q36008291 | Stability of RNA stem-loop structure and distribution of non-random structure in the human immunodeficiency virus (HIV-I). |
| Q38172146 | Strategies for antiviral therapy in AIDS. |
| Q27652984 | Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV |
| Q36802812 | Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. |
| Q64107839 | Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat |
| Q33886447 | Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase |
| Q37328987 | Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function |
| Q70521479 | The DNA-binding properties of an artificial 42-residue polypeptide derived from a natural repressor |
| Q59060595 | The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice |
| Q35829282 | The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency |
| Q34646173 | The effect of structure in a long target RNA on ribozyme cleavage efficiency |
| Q37783051 | The human immunodeficiency virus TAT protein. A target for antiviral agents |
| Q40597354 | The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression |
| Q28298912 | The regulatory mechanisms of human immunodeficiency virus replication predict multiple expression rates |
| Q77776111 | Thioredoxin and mechanism of inflammatory response |
| Q34344850 | Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events |
| Q40526004 | Transactivation of heterologous promoters by HIV-1 tat. |
| Q40506561 | USF-related transcription factor, HIV-TF1, stimulates transcription of human immunodeficiency virus-1. |
| Q39608040 | Use of transgenic animals to study human retroviruses |
| Q36920436 | trans-acting factors interact with a cyclic AMP response element to modulate expression of the human gonadotropin alpha gene |
Search more.